Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,759
  • Shares Outstanding, K 12,803
  • Annual Sales, $ 520 K
  • Annual Income, $ -16,610 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 3.02
  • Price/Sales 2.91
  • Price/Cash Flow N/A
  • Price/Book 0.87
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.02
  • Most Recent Earnings $-0.27 on 11/26/25
  • Next Earnings Date 03/25/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 434.80% (+14.00%)
  • Historical Volatility 245.35%
  • IV Percentile 85%
  • IV Rank 41.75%
  • IV High 944.80% on 10/27/25
  • IV Low 69.34% on 09/19/25
  • Expected Move (DTE 13) 0.1700 (28.05%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 3
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 1.26
  • Today's Open Interest 140
  • Open Int (30-Day) 147
  • Expected Range 0.4360 to 0.7760

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +293,923.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4950 +22.42%
on 03/02/26
0.8100 -25.19%
on 02/09/26
-0.1939 (-24.24%)
since 02/06/26
3-Month
0.4950 +22.42%
on 03/02/26
2.0799 -70.86%
on 12/08/25
-1.4040 (-69.85%)
since 12/05/25
52-Week
0.4950 +22.42%
on 03/02/26
4.9800 -87.83%
on 05/29/25
-2.4540 (-80.20%)
since 03/06/25

Most Recent Stories

More News
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

REHOVOT, Israel , Feb. 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on...

CLGN : 0.6060 (-4.52%)
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

REHOVOT, Israel , Feb. 23, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...

CLGN : 0.6060 (-4.52%)
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in patients experiencing volume depletion linked to GLP-1 weight-loss therapies

CLGN : 0.6060 (-4.52%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING

REHOVOT, Israel , Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.6060 (-4.52%)
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

REHOVOT, Israel , Nov. 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.6060 (-4.52%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.6060 (-4.52%)
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

-- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen and BioInks as well as enable logistical efficiencies --

CLGN : 0.6060 (-4.52%)
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology

REHOVOT, Israel , Oct. 20, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...

CLGN : 0.6060 (-4.52%)
CollPlant and Mayo Clinic Unveil Humanized 3D Bioprinted Skin Model

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

CLGN : 0.6060 (-4.52%)
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

REHOVOT, Israel , Oct. 16, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its...

CQPTY : 9.0000 (+1.69%)
CLGN : 0.6060 (-4.52%)

Business Summary

CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw...

See More

Key Turning Points

3rd Resistance Point 0.8127
2nd Resistance Point 0.7713
1st Resistance Point 0.6887
Last Price 0.6060
1st Support Level 0.5647
2nd Support Level 0.5233
3rd Support Level 0.4407

See More

52-Week High 4.9800
Fibonacci 61.8% 3.2667
Fibonacci 50% 2.7375
Fibonacci 38.2% 2.2083
Last Price 0.6060
52-Week Low 0.4950

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar